본문 바로가기
KERD
논문KCI 등재

중등도 이하 아토피 피부염에 영향을 미치는 환자 요인

Aggravating and Mitigating Patient Factors Affecting Mild to ModerateAtopic Dermatitis

김윤범|강동원
대한한방안이비인후피부과학회 (The Korean Medicine Opthalmology&Otolaryngology&Dermatology Society)|2020.11|한방안이비인후피부과학회지 (The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology)|제33권 제4호|pp. 1-15|DOI http://dx.doi.org/10.6114/jkood.2020.33.4.001

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

Factor AnalysisCorrelationAtopic DermatitisSkin MoistureSCORAD IndexAggravating FactorMitigating Factor
주제분류한의학

초록

Objectives : To investigate aggravating and mitigating factors of atopic dermatitis and to utilize the outcome in treatment planning. Methods : The research has a cross-sectional study design. Patients’ SCORing Atopic Dermatitis (SCORAD) Index, demographic, physical characteristics, social history, serologic index and skin related instrumental measurements were analyzed with correlation and regression analysis method. Results : 48 patients in total were enrolled in the study. Skin Surface Hydration (SSH) and sex were found to be statistically significant aggravating and mitigating factors. As SSH increased, Total SCORAD (tSCORAD) and Objective SCORAD (oSCORAD) increased as well. As SSH decreased, tSCORAD and oSCORAD decreased as well. Female patient had a higher probability of suffering from severer subjective symptoms than that of male. Age, body mass index (BMI), alcohol consumption and smoking, transepidermal water loss (TEWL), IgE, IL-4, IL-5, IL-6, IFN-γ were found not to be statistically significant. There was no correlation between Subjective SCORAD (sSCORAD) and oSCORAD neither with Eczema Area and Severity Index (EASI). Conclusions : Increasing cutaneous moisture should be included in the treatment plan of atopic dermatitis. More emphasis should be put on alleviating subjective discomforts of female patients than that of male. Establishing separate strategies of managing objective eczema status and subjective discomforts respectively should be considered.

Abstract

Objectives : To investigate aggravating and mitigating factors of atopic dermatitis and to utilize the outcome in treatment planning. Methods : The research has a cross-sectional study design. Patients’ SCORing Atopic Dermatitis (SCORAD) Index, demographic, physical characteristics, social history, serologic index and skin related instrumental measurements were analyzed with correlation and regression analysis method. Results : 48 patients in total were enrolled in the study. Skin Surface Hydration (SSH) and sex were found to be statistically significant aggravating and mitigating factors. As SSH increased, Total SCORAD (tSCORAD) and Objective SCORAD (oSCORAD) increased as well. As SSH decreased, tSCORAD and oSCORAD decreased as well. Female patient had a higher probability of suffering from severer subjective symptoms than that of male. Age, body mass index (BMI), alcohol consumption and smoking, transepidermal water loss (TEWL), IgE, IL-4, IL-5, IL-6, IFN-γ were found not to be statistically significant. There was no correlation between Subjective SCORAD (sSCORAD) and oSCORAD neither with Eczema Area and Severity Index (EASI). Conclusions : Increasing cutaneous moisture should be included in the treatment plan of atopic dermatitis. More emphasis should be put on alleviating subjective discomforts of female patients than that of male. Establishing separate strategies of managing objective eczema status and subjective discomforts respectively should be considered.

참고문헌 (48)

  1. Sacotte R, "Epidemiology of adult atopic dermatitis", Clin Dermatol, 36(5), pp.595~605 (2018)
  2. Weidinger S, "Atopic dermatitis", Lancet, 387(10023), pp.1109~1122 (2016)
  3. Mozaffari H, "Quality of life in atopic dermatitis patients", J Microbiol Immunol Infect, 40(3), pp.260~264 (2007)
  4. Egawa G, "Multifactorial skin barrier deficiency and atopic dermatitis : Essential topics to prevent the atopic march", J Allergy Clin Immunol, 138(2), pp.350~358 (2016)
  5. Nomura T, "Advances in atopic dermatitis in 2015", J Allergy Clin Immunol, 138(6), pp.1548~1555 (2016)
  6. Fonacier LS, "Allergic skin diseases", J Allergy Clin Immunol., 125(2 Suppl 2), pp.S138~S149 (2010)
  7. 김영휘, "2009년 학동 전기 소아에서 알레르기질환의 유병률과 위험인자", Allergy Asthma & Respiratory Disease, 21(3), pp.165~175 (2011), 대한 소아알레르기 호흡기학회
  8. Baek JO, "Analysis of the prevalence of and risk factors for atopic dermatitis using an ISAAC questionnaire in 8,750 Korean children", Int Arch Allergy Immunol, 162(1), pp.79~85 (2013)
  9. Park YM, "Risk factors of atopic dermatitis in Korean schoolchildren : 2010 international study of asthma and allergies in childhood", Asian Pac J Allergy Immunol, 34(1), pp.65~72 (2016)
  10. 박용민, "아토피피부염 역학조사와 위험인자", Allergy Asthma & Respiratory Disease, 21(2), pp.74~77 (2011), 대한 소아알레르기 호흡기학회
  11. Choi WJ, "Prevalence and risk factors for atopic dermatitis : a cross-sectional study of 6, 453 Korean preschool children", Acta Derm Venereol, 92(5), pp.467~471 (2012)
  12. Yi O, "Effect of environmental tobacco smoke on atopic dermatitis among children in Korea", Environ Res, 113, pp.40~45 (2012)
  13. "Severity scoring of atopic dermatitis: the SCORAD Index. Consensus Report of the European Task Force on Atopic Dermatitis", Dermatology, 186(1), pp.23~31 (1993)
  14. Charman C, "Measuring atopic dermatitis severity in randomized controlled clinical trials : what exactly are we measuring", J Invest Dermatol, 120(6), pp.932~941 (2003)
  15. Rehal B, "Health outcome measures in atopic dermatitis : a systematic review of trends in disease severity and quality-of-life instruments 1985-2010", PLoS One, 6(4), pp.e17520~ (2011)
  16. Hill MK, "Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis : A systematic review", J Am Acad Dermatol, 75(5), pp.906~917 (2016)
  17. Park JG, "Acupuncture Treatment for Symptom Management in Atopic Dermatitis : A Study Protocol for a Randomized, Participant-and Assessor-Blind, Sham-Controlled Trial", Evid Based Complement Alternat Med, 2019, pp.1907578~ (2019)
  18. Kunz B, "Clinical validation and guidelines for the SCORAD Index : consensus report of the European Task Force on Atopic Dermatitis", Dermatology, 195(1), pp.10~19 (1997)
  19. Oranje AP, "Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines", ETAC Study Group. Early Treatment of the Atopic Child. Pediatr Allergy Immunol, 8(1), pp.28~34 (1997)
  20. Schmitt J, "What are the best outcome measurements for atopic eczema? A systematic review", J Allergy Clin Immunol, 120(6), pp.1389~1398 (2007)
  21. Bozek A, "Assessment of Intra-and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity : EASI, Objective SCORAD, and IGA", Dermatology, 233(1), pp.16~22 (2017)
  22. Hanifin JM, "The eczema area and severity Index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group", Exp Dermatol, 10(1), pp.11~18 (2001)
  23. Chopra R, "Severity strata for Eczema Area and Severity Index(EASI), modified EASI, Scoring Atopic Dermatitis(SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis", Br J Dermatol, 177(5), pp.1316~1321 (2017)
  24. Barbier N, "Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550patients from the pimecrolimus cream 1%randomized controlled clinical trials programme", Br J Dermatol, 150(1), pp.96~102 (2004)
  25. Barel AO, "In vitro calibration of the capacitance method(Corneometer CM 825)and conductance method(Skicon-200)for the evaluation of the hydration state of the skin", Skin Res Technol, 3(2), pp.107~113 (1997)
  26. 황선욱, "아토피피부염 환자의 치료경과에 따른 중증도 평가에서 SCORAD Index와 기계적 측정값과의 상관관계", 대한피부과학회지, 48(4), pp.266~271 (2010), 대한피부과학회
  27. Miteva M, "Approaches for optimizing the calibration standard of Tewameter TM 300", Exp Dermatol, 15(11), pp.904~912 (2006)
  28. Shaw TE, "Eczema prevalence in the United States : data from the 2003 National Survey of Children's Health", J Invest Dermatol, 131(1), pp.67~73 (2011)
  29. Brunekreef B, "Self-reported truck traffic on the street of residence and symptoms of asthma and allergic disease : a global relationship in ISAAC phase 3", Environ Health Perspect, 117(11), pp.1791~1798 (2009)
  30. Ellwood P, "Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood(ISAAC)phase three", Thorax, 68(4), pp.351~360 (2013)
  31. Foliaki S, "Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old : International Study of Asthma and Allergies in Childhood Phase III", J Allergy Clin Immunol, 124(5), pp.982~989 (2009)
  32. Mitchell EA, "The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents : analyses from Phase Three of the ISAAC programme", Thorax, 67(11), pp.941~949 (2012)
  33. Asher MI, "International Study of Asthma and Allergies in Childhood(ISAAC) : rationale and methods", Eur Respir J, 8(3), pp.483~491 (1995)
  34. Holm EA, "Assessment of atopic eczema : clinical scoring and noninvasive measurements", Br J Dermatol, 157(4), pp.674~680 (2007)
  35. Elias PM, "Basis for the barrier abnormality in atopic dermatitis : outside-inside-outside pathogenic mechanisms", J Allergy Clin Immunol, 121(6), pp.1337~1343 (2008)
  36. Eichenfield LF, "Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis", J Am Acad Dermatol, 70(2), pp.338~351 (2014)
  37. Ziyab AH, "Trends in eczema in the first 18 years of life : results from the Isle of Wight 1989 birth cohort study", Clin Exp Allergy, 40(12), pp.1776~1784 (2010)
  38. Schultz Larsen F, "Secular change in the occurrence of atopic dermatitis", Acta Derm Venereol Suppl(Stockh), 176, pp.7~12 (1992)
  39. Vlaski E, "Overweight hypothesis in asthma and eczema in young adolescents", Allergol Immunopathol(Madr), 34(5), pp.199~205 (2006)
  40. Sybilski AJ, "Obesity--a risk factor for asthma, but not for atopic dermatitis, allergic rhinitis and sensitization", Public Health Nutr, 18(3), pp.530~536 (2015)
  41. Lee SI, "Prevalences of symptoms of asthma and other allergic diseases in korean children : a nationwide questionnaire survey", J Korean Med Sci, 16(2), pp.155~164 (2001)
  42. Silverberg JI, "Association between obesity and atopic dermatitis in childhood : a case-control study", J Allergy Clin Immunol, 127(5), pp.1180~1186 (2011)
  43. Mitchell EA, "The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents : ISAAC Phase Three", Clin Exp Allergy, 43(1), pp.73~84 (2013)
  44. Martin-Romero C, "Human leptin enhances activation and proliferation of human circulating T lymphocytes", Cell Immunol, 199(1), pp.15~24 (2000)
  45. Kerkhof M, "Risk factors for atopic dermatitis in infants at high risk of allergy : the PIAMA study", Clin Exp Allergy, 33(10), pp.1336~1341 (2003)
  46. Kabashima K, "New concept of the pathogenesis of atopic dermatitis : interplay among the barrier, allergy, and pruritus as a trinity", J Dermatol Sci, 70(1), pp.3~11 (2013)
  47. Arbes SJ, Jr, "Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey", J Allergy Clin Immunol, 116(2), pp.377~383 (2005)
  48. 박근화, "SCORing atopic dermatitis index로 평가한 아토피피부염의 중증도와 혈액 검사와의 연관성", Allergy Asthma & Respiratory Disease, 1(1), pp.79~83 (2013), 대한 소아알레르기 호흡기학회

이 간행물의 다른 논문 (11건)

둔산한방병원 한방안이비인후피부과 내원 피부질환 환자 특성 분석 - 2016년 3월부터 2019년 2월까지 -정현아, 김수영pp. 16-31한국산 동백종자 초임계 추출물의 피부 항산화 및 항노화 연구곽병문, 김희택, 김이화, 김태준pp. 32-43Caffeine 및 광자극 유발 스트레스 동물모델에서 구기자 복합물이 스트레스 완화 및 혈중 멜라토닌에 미치는 영향김이화, 김희택, 김용민, 황동석pp. 44-54알레르기 비염의 비강 내 광 치료 : 체계적 문헌고찰민경진, 이동효, 강정인pp. 55-73알레르기 비염에 대한 小靑龍湯의 효과 평가 연구 : 체계적 문헌고찰과 메타분석신선호, 강정인, 민경진, 이동효pp. 74-99
원문 보기